2011 Fiscal Year Final Research Report
Novel cancer therapeutic strategies to target RCAS1
| Project/Area Number |
21592134
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | Kyushu University |
|---|
Principal Investigator |
SONODA Kenzo 九州大学, 大学病院, 講師 (30294929)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Keywords | RCAS1 / リンパ球アポトーシス / 腫瘍間質組織 / 血管新生 / ectodomain shedding / 悪性腫瘍 / 治療標的分子 |
|---|
| Research Abstract |
RCAS1 can induce apoptosis in immune cells including peripheral lymphocytes and natural killer cells after converted to a secreted type by ectodomain shedding. Because RCAS1 not only helps tumor cells to evade immune surveillance but also induces cancer stromal tissue remodeling, RCAS1 is believed to exaggerate aggressive characteristics of human malignancies. Clinically, RCAS1 expression correlates with several pathological variables including tumor size, stage, invasion depth, and lymph node metastasis and is a negative predictor of overall survival in 15 different kinds of cancer. Novel therapeutic strategies against cancer are now under development by targeting an intriguing biomarker RCAS1.
|
Research Products
(16 results)
